Format
Sort by

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 138

1.

Clinical efficacy of amiodarone as an antiarrhythmic agent.

Rosenbaum MB, Chiale PA, Halpern MS, Nau GJ, Przybylski J, Levi RJ, Lázzari JO, Elizari MV.

Am J Cardiol. 1976 Dec;38(7):934-44.

PMID:
793369
2.

Clinical efficacy of amiodarone in treatment of recurrent ventricular tachycardia and ventricular fibrillation.

Heger JJ, Prystowsky EN, Zipes DP.

Am Heart J. 1983 Oct;106(4 Pt 2):887-94.

PMID:
6613835
3.

Amiodarone in long term management of refractory cardiac tachyarrhythmias.

Lubbe WF, Mercer CJ, Roche AH, Lowe JB.

N Z Med J. 1981 Jan 28;93(676):31-5.

PMID:
6940024
4.

Ten years of experience with amiodarone.

Rosenbaum MB, Chiale PA, Haedo A, Lázzari JO, Elizari MV.

Am Heart J. 1983 Oct;106(4 Pt 2):957-64.

PMID:
6613843
5.

High incidence of clinical and subclinical toxicity associated with amiodarone treatment of refractory tachyarrhythmias.

Anastasiou-Nana MI, Anderson JL, Nanas JN, Lutz JR, Smith RA, Anderson KP, Crapo RO, Call NB.

Can J Cardiol. 1986 May-Jun;2(3):138-45.

PMID:
2941121
6.

Amiodarone: a unique antiarrhythmic agent.

Sloskey GE.

Clin Pharm. 1983 Jul-Aug;2(4):330-40. Review.

PMID:
6349912
7.

Amiodarone: electrophysiologic actions, pharmacokinetics and clinical effects.

Zipes DP, Prystowsky EN, Heger JJ.

J Am Coll Cardiol. 1984 Apr;3(4):1059-71. Review.

PMID:
6368644
8.

Control of refractory cardiac arrhythmias with amiodarone.

Leak D, Eydt JN.

Arch Intern Med. 1979 Apr;139(4):425-8.

PMID:
434996
9.

Efficacy of amiodarone during long-term treatment of malignant ventricular arrhythmias in patients with chronic chagasic myocarditis.

Chiale PA, Halpern MS, Nau GJ, Tambussi AM, Przybylski J, Lázzari JO, Elizari MV, Rosenbaum MB.

Am Heart J. 1984 Apr;107(4):656-65.

PMID:
6702559
10.

Arrhythmias in the intensive care patient.

Trappe HJ, Brandts B, Weismueller P.

Curr Opin Crit Care. 2003 Oct;9(5):345-55. Review.

PMID:
14508146
12.

Amiodarone treatment in patients with ventricular arrhythmias.

Prystowsky EN, Heger JJ, Miles WM, Zipes DP.

Drugs. 1985 Mar;29 Suppl 3:47-52.

PMID:
3996245
13.

Amiodarone: clinical trials.

Naccarelli GV, Wolbrette DL, Patel HM, Luck JC.

Curr Opin Cardiol. 2000 Jan;15(1):64-72. Review.

PMID:
10666663
14.

Amiodarone for refractory cardiac arrhythmias: 10-year study.

Leak D, Eydt JN.

CMAJ. 1986 Mar 1;134(5):495-501.

15.
16.

Amiodarone for control of sustained ventricular tachyarrhythmia: clinical and electrophysiologic effects in 51 patients.

Waxman HL, Groh WC, Marchlinski FE, Buxton AE, Sadowski LM, Horowitz LN, Josephson ME, Kastor JA.

Am J Cardiol. 1982 Nov;50(5):1066-74.

PMID:
6291368
17.
18.

Effect of low oral doses of disopyramide and amiodarone on ventricular and atrial arrhythmias of chagasic patients with advanced myocardial damage.

Carrasco HA, Vicuña AV, Molina C, Landaeta A, Reynosa J, Vicuña N, Fuenmayor A, López F.

Int J Cardiol. 1985 Dec;9(4):425-38.

PMID:
3908329
19.

Amiodarone: clinical efficacy and toxicity in 96 patients with recurrent, drug-refractory arrhythmias.

Fogoros RN, Anderson KP, Winkle RA, Swerdlow CD, Mason JW.

Circulation. 1983 Jul;68(1):88-94.

PMID:
6851057
20.

Amiodarone therapy for life threatening or refractory cardiac arrhythmias.

Johns JA, Harper RW, Currie PJ, Federman J, Anderson ST, Pitt A.

Aust N Z J Med. 1983 Jun;13(3):248-56.

PMID:
6579938
Items per page

Supplemental Content

Write to the Help Desk